[Advantan for therapy of atopic dermatitis].
Atopic dermatitis is a common, chronic skin disease characterized by dry, itchy and easily irritated skin. It occurs most commonly in infants and young children, but can persist into adulthood. Severe cases can lead to sleep deprivation, chronic bacterial infections, and depression. Along with other allergic diseases, its prevalence has grown significantly in recent years. Topical medicines are the most common and effective treatment for atopic dermatitis. Drugs taken orally and used to suppress the immune system have been converted into an ointment or cream. These topical immunosuppressive agents are being used now to treat eczema. Advantan (0.1% methylprednisolone aceponate) is indicated for the treatment of eczema and other inflammatory skin disorders as a highly effective topical corticosteroid. The effect of Advantan in the treatment of atopic dermatitis was studied. A clinical study of Advantan ointment involved 26 patients aged between 6 and 56 years with atopic dermatitis. Positive therapeutic effect was achieved in the overwhelming majority of the patients (n=25). It was concluded that Advantan ointment produced by Schering AC had marked antiinflammatory and antipruritic action. It was convenient to use and well tolerated by the patients. It is concluded that Advantan may be used for the treatment of patients with atopic dermatitis.
Beridze
L R
LR
Zosidze
N R
NR
D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002648:Child; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008875:Middle Aged; D009824:Ointments; D016896:Treatment Outcome; D055815:Young Adult
D000893:Anti-Inflammatory Agents; D009824:Ointments; C078007:methylprednisolone aceponate; D008775:Methylprednisolone